StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Genetic Sciences by Year

Genetic Sciences (Gene Sequencing, qPCR & Genetic Analysis) ($M)

Thermo Fisher Scientific Genetic Sciences: $2,870M in FY2025, up 3.0% from a year earlier.

Latest, FY2025
2,870
Period ended Dec 31, 2025
Change on a year earlier
+3.0%
2,787 in FY2024
History
3 years
Since FY2023
Sources
1
SEC Form 10-K (10k_2025, filed 2026-02-26)

Where the FY2025 figure comes from

“|| Genetic sciences | 2,870 | 2,787 | 2,816”

Source: SEC Form 10-K (10k_2025, filed 2026-02-26) ↗

Reported in SEC 10-K / 10-Q Note 6 (Revenue by Business).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGenetic Sciences (Gene Sequencing, qPCR & Genetic Analysis) ($M)Year on yearSource
FY2025Dec 31, 20252,870+3.0%SEC Form 10-K (10k_2025, filed 2026-02-26) ↗
FY2024Dec 31, 20242,787-1.0%SEC Form 10-K (10k_2025, filed 2026-02-26) ↗
FY2023Dec 31, 20232,816–SEC Form 10-K (10k_2025, filed 2026-02-26) ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Genetic Sciences ($M), annual FY2023–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/rev-biz-genetic-sciences

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.